«Differential cellular effects of sunitinib and pazopanib targeted drugs for metastatic renal cell carcinoma: an in vitro approach», RevSALUS, vol. 4, n. Sup, pp. 167–168, Abr. 2022, doi: 10.51126/revsalus.v4iSup.401.